• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类物质使用障碍患者认知灵活性的相关因素:一项初步研究。

Factors associated with cognitive flexibility in people with opioid-use disorder: a pilot study.

作者信息

Regier Paul S, Macedo de Arruda Thais Costa, Sinko Laura, Teitelman Anne M, Childress Anna Rose

机构信息

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Psychology and Neuroscience Department, College of Liberal Arts, Temple University, Philadelphia, PA, United States.

出版信息

Front Psychiatry. 2024 Dec 19;15:1505391. doi: 10.3389/fpsyt.2024.1505391. eCollection 2024.

DOI:10.3389/fpsyt.2024.1505391
PMID:39748901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11693614/
Abstract

The ability to adapt to changing circumstances has strong survival value. Individuals with substance use disorders tend to get "stuck" over-responding to drug-reward signals and pursuing drugs despite negative consequences. A lack of flexibility may be tied to impairments in neurocognition, including learning, memory, and executive function. However, results are often mixed, potentially due to heterogeneity in factors such as mental health, personality traits, or prior adversity. This study aimed to identify which factors influence neurocognitive variations within the opioid use disorder (OUD) population. Based on prior literature, we hypothesized that individuals with OUD would show deficits (vs. controls) in one or more neurocognitive domains, and that these cognitive difficulties might be greater in individuals with other known contributors to impaired cognition. This pilot project included 32 individuals receiving medication for OUD and 15 non-substance using controls (NSC). Questionnaires assessed addiction and relapse risk factors, such as impulsiveness, social function, depressive symptoms, and childhood adversity. Neurocognitive performance was measured via the Penn Computerized Neurocognitive Battery (P-CNB), including tasks that probe attention, working memory, episodic memory, cognitive flexibility, and complex cognition, and was compared between the OUD and NSC groups. OUD participants (vs. NSCs) exhibited significantly lower performance on the conditional exclusion task (CET) (Accuracy: 1.11 vs. 2.38, p < 0.001) and the n-Back task (NBT) (F1 Scores: 83% vs. 95%, p < 0.001). Impulsiveness, social function, and depressive symptoms were highly inter-related; however, only higher impulsiveness (r = -.48, p = 0.006) and more social impairment (r = -.47, p = 0.007) significantly correlated with decreased CET (but not n-Back) performance. This pilot study suggests that working memory and cognitive flexibility are impaired in people with OUD and that impulsiveness and social function are key factors in cognitive flexibility impairments in people with OUD. These results may offer insights for larger-scale investigations and potential interventions to reduce relapse risk.

摘要

适应不断变化的环境的能力具有很强的生存价值。患有物质使用障碍的个体往往会“陷入困境”,尽管有负面后果,仍会对药物奖励信号过度反应并追求药物。缺乏灵活性可能与神经认知障碍有关,包括学习、记忆和执行功能。然而,结果往往参差不齐,这可能是由于心理健康、人格特质或既往逆境等因素的异质性所致。本研究旨在确定哪些因素会影响阿片类药物使用障碍(OUD)人群的神经认知差异。基于先前的文献,我们假设患有OUD的个体在一个或多个神经认知领域会表现出缺陷(与对照组相比),并且这些认知困难在有其他已知认知受损因素的个体中可能会更大。这个试点项目包括32名接受OUD药物治疗的个体和15名非物质使用对照组(NSC)。问卷调查评估了成瘾和复发风险因素,如冲动性、社交功能、抑郁症状和童年逆境。通过宾夕法尼亚计算机化神经认知测试电池(P-CNB)测量神经认知表现,包括探测注意力、工作记忆、情景记忆、认知灵活性和复杂认知的任务,并在OUD组和NSC组之间进行比较。OUD参与者(与NSC相比)在条件排除任务(CET)(准确率:1.11对2.38,p<0.001)和n-回溯任务(NBT)(F1分数:83%对95%,p<0.001)上表现出显著更低的成绩。冲动性、社交功能和抑郁症状高度相关;然而,只有更高的冲动性(r = -0.48,p = 0.006)和更多的社交障碍(r = -0.47,p = 0.007)与CET成绩下降(但与n-回溯任务无关)显著相关。这项试点研究表明,OUD患者的工作记忆和认知灵活性受损,冲动性和社交功能是OUD患者认知灵活性受损的关键因素。这些结果可能为大规模调查和降低复发风险的潜在干预措施提供见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c01/11693614/166499115157/fpsyt-15-1505391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c01/11693614/0c6494a28868/fpsyt-15-1505391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c01/11693614/166499115157/fpsyt-15-1505391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c01/11693614/0c6494a28868/fpsyt-15-1505391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c01/11693614/166499115157/fpsyt-15-1505391-g002.jpg

相似文献

1
Factors associated with cognitive flexibility in people with opioid-use disorder: a pilot study.阿片类物质使用障碍患者认知灵活性的相关因素:一项初步研究。
Front Psychiatry. 2024 Dec 19;15:1505391. doi: 10.3389/fpsyt.2024.1505391. eCollection 2024.
2
Neurocognition in youth with versus without prediabetes.有与无糖尿病前期的青年的神经认知情况
medRxiv. 2025 Jun 23:2025.06.23.25330130. doi: 10.1101/2025.06.23.25330130.
3
Short-Term Memory Impairment短期记忆障碍
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
6
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.痴呆症老年人行为和心理症状的慢性抗精神病药物撤药与继续用药对比
Cochrane Database Syst Rev. 2013 Mar 28(3):CD007726. doi: 10.1002/14651858.CD007726.pub2.
7
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.脑损伤儿童和青少年记忆与执行功能康复的技术辅助手段。
Cochrane Database Syst Rev. 2016 Jul 1;7(7):CD011020. doi: 10.1002/14651858.CD011020.pub2.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.

引用本文的文献

1
Computational mechanisms underlying multi-step planning deficits in methamphetamine use disorder.甲基苯丙胺使用障碍中多步计划缺陷的计算机制。
Transl Psychiatry. 2025 May 24;15(1):181. doi: 10.1038/s41398-025-03390-8.

本文引用的文献

1
A Study of the association of neurocognition with relapse and quality of life in patients of alcohol dependence.酒精依赖患者神经认知与复发及生活质量的相关性研究。
Ind Psychiatry J. 2024 Jan-Jun;33(1):133-140. doi: 10.4103/ipj.ipj_158_23. Epub 2024 Feb 16.
2
Patterns of Adverse Childhood Experiences and Neurocognitive Development.童年不良经历模式与神经认知发展
JAMA Pediatr. 2024 Jul 1;178(7):678-687. doi: 10.1001/jamapediatrics.2024.1318.
3
Comparing attention, impulsivity, and executive functions between patients with opiate use disorder: Buprenorphine maintenance treatment versus active users, in comparison with healthy controls.
比较阿片类药物使用障碍患者之间的注意力、冲动性和执行功能:丁丙诺啡维持治疗者与活跃使用者,与健康对照相比。
Indian J Psychiatry. 2024 Jan;66(1):90-97. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_520_23. Epub 2024 Jan 25.
4
Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study.阿片类药物戒断对患有阿片类药物使用障碍男性神经心理表现的影响:一项纵向研究。
J Addict Med. 2023;17(5):557-562. doi: 10.1097/ADM.0000000000001177. Epub 2023 May 18.
5
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.MDMA 辅助治疗中重度 PTSD:一项随机、安慰剂对照的 3 期试验。
Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14.
6
Neurocognitive predictors of addiction-related outcomes: A systematic review of longitudinal studies.神经认知预测因子与成瘾相关结局:纵向研究的系统综述。
Neurosci Biobehav Rev. 2023 Sep;152:105295. doi: 10.1016/j.neubiorev.2023.105295. Epub 2023 Jun 28.
7
Psychedelics and Neural Plasticity: Therapeutic Implications.迷幻药与神经可塑性:治疗意义。
J Neurosci. 2022 Nov 9;42(45):8439-8449. doi: 10.1523/JNEUROSCI.1121-22.2022.
8
Towards an understanding of psychedelic-induced neuroplasticity.迈向对迷幻剂引起的神经可塑性的理解。
Neuropsychopharmacology. 2023 Jan;48(1):104-112. doi: 10.1038/s41386-022-01389-z. Epub 2022 Sep 19.
9
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比:一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
10
Meta-analytic evidence for downregulation of the amygdala during working memory maintenance.工作记忆维持期间杏仁核下调的荟萃分析证据。
Hum Brain Mapp. 2022 Jun 15;43(9):2951-2971. doi: 10.1002/hbm.25828. Epub 2022 Mar 29.